Cargando…
Evaluation of EGFR mutations in NSCLC with highly sensitive droplet digital PCR assays
Targeted drugs have been widely used in the treatment of patients with lung cancer, particularly for those with non-small cell lung cancer (NSCLC). Plasma cell-free DNA is an emerging clinical tool for the detection of epidermal growth factor receptor (EGFR) gene mutation in patients with lung cance...
Autores principales: | Jiang, Xi-Wen, Liu, Wei, Zhu, Xiao-Ya, Xu, Xiao-Xie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580028/ https://www.ncbi.nlm.nih.gov/pubmed/31115577 http://dx.doi.org/10.3892/mmr.2019.10259 |
Ejemplares similares
-
Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
por: Hackner, Klaus, et al.
Publicado: (2021) -
Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation
por: ZHANG, BO, et al.
Publicado: (2015) -
Comparison of the SuperARMS and Droplet Digital PCR for Detecting EGFR Mutation in ctDNA From NSCLC Patients
por: Feng, Wei-neng, et al.
Publicado: (2018) -
Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay
por: Guo, Qiao-mei, et al.
Publicado: (2019) -
Evaluation of Droplet Digital PCR Assay for the Diagnosis of Candidemia in Blood Samples
por: Chen, Biao, et al.
Publicado: (2021)